Product Name

Molecular Formula

Sequence

PENK(114-133) (By similarity)

C₉₅H₁₄₆N₂₂O₃₆S₂

MDELYPMEPEEEANGGEILA

PENK(114-133)

C₉₅H₁₄₆N₂₂O₃₆S

MDELYPVEPEEEANGGEILA

PENK(111-130) (By similarity)

C₉₄H₁₄₆N₂₂O₃₆S

MDELYPLEVEEEANGGEVLG

PENK 114-133 (7-20)

C₆₁H₉₇N₁₅O₂₆

VEPEEEANGGEILA

PEN-20

C₉₁H₁₄₉N₂₃O₃₁

SVDQDLGPEVPPENVLGALL

PEN-20

C₉₁H₁₄₉N₂₃O₃₀

AVDQDLGPEVPPENVLGALL

PEN-19

C₈₅H₁₃₈N₂₂O₃₀

SVDQDLGPEVPPENVLGAL

PEN fragment of proSAAS

C₁₀₂H₁₆₉N₂₇O₃₃

AVDQDLGPEVPPENVLGALLRV

PEN fragment of proSAAS

C₉₇H₁₅₉N₂₇O₃₂

AADHDVGSELPPEGVLGALLRV

PEG-PQ

C₅₀H₇₆N₁₆O₁₅

H-GGGPQGIWGQGK-OH

PEG-PQ

C₄₈H₇₃N₁₅O₁₄

H-GGGPQGIWGQK-OH

PE1

KIKFLKVLT

PDSGR

C₂₂H₃₆N₈O₁₀

Ac-PDSGR-OH

PDL101/PDL1 15–23

C₄₆H₇₆N₁₀O₁₃

H-LLNAFTVTV-OH

PDKtide

C₂₁₂H₃₁₄N₅₄O₆₆S₃

H-KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC-OH

PDHPS1

C₈₁H₁₄₃N₂₅O₂₈

H-IATTTASAATAAAIGATPRAK-OH

PDGFRtide

C₅₄H₇₆N₁₀O₂₀

QEEEYVFIE

PDGF b-Receptor (719-723) (phosphorylated)

PDGF

PDGF Antagonist

C₇₇H₁₂₂N₂₀O₁₇

ANFLVWEIVRKKP

PD-LYSO

C₂₃₄H₃₇₂N₆₀O₇₆S₄

H-DKEMAATSAAIEDAVRRIEDMMNQYPYDVPDYAMDFSGLSLIKLKKQ-OH

PD-L205/PD-L2 16-25

C₅₀H₈₃N₁₁O₁₄

H-QIAALFTVTV-OH

PD-L1Pep-2

C₃₃H₆₄N₁₆O₉S

H-CVRARTR-OH

PCM-SH

C₁₀₀H₁₅₇N₂₉O₂₈S

H-CWLSEAGPVVTVRALRGTGSW-OH

PBAN-neuropeptide 2

VPWTPSPRL

PB1(703-711), Influenza

C₄₅H₇₅N₁₅O₁₃

SSYRRPVGI

PAR-4 (1-6) amide (mouse)

C₃₃H₄₆N₈O₇

GYPGKF

PAR-4 (1-6) amide (human)

C₂₈H₄₂N₈O₈

GYPGQV

PAR-4 (1-6) (mouse)

C₃₃H₄₅N₇O₈

GYPGKF

PAR-4 (1-6) (human)

C₂₈H₄₁N₇O₉

GYPGQV

PAR-3 (1-6) amide (mouse)

C₂₅H₃₆N₈O₈

SFNGGP

PAR-3 (1-6) amide (human)

C₂₉H₄₆N₁₀O₇

TFRGAP

PAR-3 (1-6) (human)

C₂₉H₄₅N₉O₈

TFRGAP

PAR-2 (6-1) amide (mouse, rat)

C₂₉H₅₆N₁₀O₇

LRGILS

PAR-2 (6-1) amide (human)

C₂₈H₅₄N₈O₇

VKGILS

PAR-2 (1-6) amide (mouse, rat)

C₂₉H₅₆N₁₀O₇

SLIGRL

PAR-2 (1-6) (mouse, rat)

C₂₉H₅₅N₉O₈

SLIGRL

PAR-2 (1-6) (human), Protease-Activated Receptor-2, PAR-2 Agonist

C₂₈H₅₃N₇O₈

SLIGKV

PAR-1 (1-6) (mouse, rat)

C₃₇H₅₄N₁₀O₉

SFFLRN

PAM2

RPWAGNGSVHRYTVLSPRLKTQ

PAM1

RTKRRIKLIKNGVKKVKDILKNNNIIILPGSNEK